Bilateral renal artery stenosis - Symptoms, Causes, Treatment & Prevention

```html

Overview

Bilateral renal artery stenosis (RAS) is the narrowing of the arteries that supply blood to both kidneys. When the lumen of each renal artery becomes narrowed—most often by atherosclerotic plaque or, less commonly, by fibromuscular dysplasia—the kidneys receive less blood flow. The reduced perfusion triggers a cascade that can raise blood pressure and impair kidney function.

Although the condition can affect anyone with risk factors for atherosclerosis, it is most common in adults over 60 years old, especially men and people with a history of cardiovascular disease. Epidemiological studies estimate that renal artery stenosis affects 1–5 % of the general adult population, and bilateral disease accounts for roughly 20 % of those cases.

Symptoms

Symptoms are often subtle and may be attributed to other conditions, which is why many patients are diagnosed incidentally during imaging for hypertension or kidney disease. The most frequently reported signs include:

• Resistant hypertension – blood pressure that remains above target despite three or more antihypertensive agents, including a diuretic.
• Sudden worsening of previously controlled hypertension – especially when the rise is rapid and unexplained.
• Reduced kidney function – a gradual rise in serum creatinine or a drop in estimated glomerular filtration rate (eGFR) without an obvious cause.
• Flash pulmonary edema – sudden fluid accumulation in the lungs, often triggered by fluid overload or a rapid increase in blood pressure.
• Abdominal or flank pain – rare, but may occur when the stenosis is severe enough to cause renal ischemia.
• Headaches, dizziness, or visual disturbances – secondary to uncontrolled hypertension.

Because many patients are asymptomatic, clinicians rely heavily on blood pressure trends and kidney‑function tests to raise suspicion.

Causes and Risk Factors

Atherosclerotic disease (the most common cause)

In adults >50 years, plaque composed of cholesterol, calcium, and inflammatory cells builds up within the renal artery wall, gradually narrowing the lumen. This process mirrors coronary artery disease and shares the same risk factors.

Fibromuscular dysplasia (FMD)

FMD is a non‑atherosclerotic, non‑inflammatory condition that typically affects women under 50 years. It creates a “string‑of‑beads” appearance on angiography due to alternating areas of stenosis and aneurysm.

Other, less common causes

• Vasculitis (e.g., Takayasu arteritis, polyarteritis nodosa)
• Arterial dissection or trauma
• External compression from adjacent masses or aneurysms

Major risk factors

• Age > 60 years – prevalence rises sharply after the sixth decade.
• Male sex – especially for atherosclerotic RAS.
• Smoking – doubles the risk of atherosclerotic lesions.
• Hyperlipidemia – high LDL cholesterol promotes plaque formation.
• Diabetes mellitus – accelerates atherosclerosis and endothelial dysfunction.
• Hypertension – both a cause and a consequence.
• Chronic kidney disease (CKD) – reduced renal reserve makes loss of perfusion more clinically evident.
• Family history of early‑onset cardiovascular disease.

Diagnosis

Diagnosing bilateral RAS requires a combination of clinical suspicion, laboratory evaluation, and imaging.

Laboratory tests

• Serum creatinine and eGFR – baseline and serial measurements to track renal function.
• Urinalysis – to look for proteinuria or hematuria that may suggest glomerular injury.
• Renin‑angiotensin‑aldosterone system (RAAS) profile – elevated plasma renin activity can support the diagnosis of renovascular hypertension.

Imaging modalities

1. Doppler Ultrasound – non‑invasive, bedside tool that measures renal‑artery velocity ratios. Sensitivity ≈80 % and specificity ≈90 % for >60 % stenosis.
2. Computed Tomography Angiography (CTA) – provides high‑resolution anatomic detail. Used when ultrasound is inconclusive; contraindicated in severe iodine allergy or advanced CKD.
3. Magnetic Resonance Angiography (MRA) – avoids ionizing radiation; gadolinium‑based contrast is avoided in patients with eGFR < 30 mL/min/1.73 m² due to nephrogenic systemic fibrosis risk.
4. Intra‑arterial Digital Subtraction Angiography (DSA) – gold standard with >95 % accuracy. Allows for simultaneous intervention (angioplasty/stenting) but carries a small risk of contrast‑induced nephropathy.

Diagnostic criteria

Most guidelines define significant stenosis as a luminal narrowing of ≥60 % on imaging, or a peak systolic velocity >200 cm/s on Doppler ultrasound, coupled with evidence of renovascular hypertension or progressive renal dysfunction.

Treatment Options

Therapy is individualized based on severity, symptom burden, renal function, and overall cardiovascular risk.

Medical Management

• Blood‑pressure control – first‑line agents include ACE inhibitors or ARBs (unless contraindicated by bilateral RAS with impaired renal function), calcium‑channel blockers, thiazide‑type diuretics, and β‑blockers.
• Lipid‑lowering therapy – high‑intensity statins (e.g., atorvastatin 40‑80 mg) reduce plaque progression.
• Antiplatelet agents – low‑dose aspirin (81 mg) recommended for atherosclerotic disease.
• Glycemic control – HbA1c <7 % (or individualized target) in diabetics.
• Smoking cessation – counseling, nicotine replacement, or pharmacotherapy (varenicline, bupropion).

Revascularization Procedures

Revascularization is considered when medical therapy fails to control blood pressure, renal function deteriorates, or flash pulmonary edema recurs.

1. Percutaneous Transluminal Renal Angioplasty (PTRA) with Stenting – most widely performed. Randomized trials (e.g., ASTRAL, CORAL) showed modest blood‑pressure benefit but no clear survival advantage; however, selected subgroups (refractory hypertension, rapid GFR decline) do benefit.
2. Open Surgical Revascularization – bypass grafting or endarterectomy. Reserved for patients unsuitable for endovascular approach or with complex disease.
3. Renal Sympathetic Denervation (experimental) – being studied as an adjunct for resistant hypertension.

Lifestyle Modifications

• Adopt a DASH (Dietary Approaches to Stop Hypertension) eating plan – rich in fruits, vegetables, low‑fat dairy, and reduced sodium (<1,500 mg/day).
• Engage in aerobic activity ≥150 minutes/week (e.g., brisk walking).
• Maintain body‑mass index (BMI) 18.5‑24.9 kg/m².
• Limit alcohol to ≤2 drinks/day for men, ≤1 drink/day for women.

Living with Bilateral Renal Artery Stenosis

Monitoring

• Check blood pressure at home—target <130/80 mmHg (or as directed by your provider).
• Serum creatinine/eGFR every 3–6 months, or sooner after medication changes.
• Annual lipid panel and hemoglobin A1c (if diabetic).

Medication adherence

Use a pill organizer, set reminders, and discuss any side effects with your clinician before stopping a drug.

Dietary tips

• Read labels for hidden sodium; choose “no‑salt‑added” or “low‑sodium” versions.
• Limit processed meats, canned soups, and fast food.
• Incorporate potassium‑rich foods (bananas, oranges) only if your doctor confirms safe kidney levels.

Physical activity

Start slowly if you have been sedentary. Walking, swimming, or cycling are kidney‑friendly. Avoid activities that cause sudden spikes in blood pressure (heavy weight‑lifting) unless cleared.

When to call your doctor

• Blood pressure consistently >180/110 mmHg.
• Sudden rise in serum creatinine (>30 % increase from baseline) over days.
• New or worsening swelling in legs, ankles, or face.
• Episodes of shortness of breath, coughing up pink frothy sputum, or chest discomfort.

Prevention

Because atherosclerotic disease underlies most cases, primary prevention mirrors cardiovascular prevention.

• Control blood pressure early—target <130/80 mmHg for most adults.
• Manage cholesterol—LDL <100 mg/dL; <70 mg/dL for high‑risk individuals.
• Quit smoking—access cessation programs.
• Maintain healthy weight and regular exercise.
• Regular medical check‑ups—especially if you have diabetes, peripheral arterial disease, or prior coronary events.

Complications

If left untreated, bilateral RAS can lead to serious sequelae.

• Refractory hypertension – markedly increased risk of stroke, myocardial infarction, and heart failure.
• Progressive chronic kidney disease – up to 30 % of patients develop end‑stage renal disease (ESRD) requiring dialysis.
• Flash pulmonary edema – recurrent episodes can be life‑threatening.
• Ischemic nephropathy – irreversible loss of renal parenchyma.
• Cardiovascular events – atherosclerotic burden in renal arteries reflects systemic disease.

When to Seek Emergency Care

---

Sources: Mayo Clinic, National Kidney Foundation, American Heart Association, CDC, NIH (National Institute of Diabetes and Digestive and Kidney Diseases), Cleveland Clinic, ASTRAL & CORAL trial publications.

```